Ad Pd 2025. Ad/pd™ is now an annual meeting, with a continuing focus on the advances in science & therapy of alzheimer’s and parkinson’s diseases and related neurological disorders. The latest findings from clinical trials.

The ad/pd™ alzheimer’s disease and parkinson’s disease conference will present all the latest breakthroughs in treatment, translational r&d, early diagnosis, drug development and clinical trials in alzheimer’s, parkinson’s and other related neurological disorders. The latest findings from clinical trials.